Michael Heile, MD, FAAFP
Advertisement
Articles by Michael Heile, MD, FAAFP
Advertisement
Latest Updated Articles
- Type 2 Diabetes in the US Managed Care Setting: The Burden of Disease and Rationale for an Oral Glucagon-like Peptide-1 Receptor Agonist
Published: December 14th 2020 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
TrumpRx Launch Brings Savings—and Uncertainty
2
How Do GLP-1 Agonists Fit Into Stroke Care?
3
5 Things to Know About the Oral GLP-1 Era
4
Addressing Disparities at Every Step of the Stroke Care Pathway: Luke Messac, MD, PhD
5
